These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of tolerability and efficacy of irreversible electroporation (IRE) in treatment of Child-Pugh B (7/8) hepatocellular carcinoma (HCC). Bhutiani N; Philips P; Scoggins CR; McMasters KM; Potts MH; Martin RC HPB (Oxford); 2016 Jul; 18(7):593-9. PubMed ID: 27346140 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings. Granata V; Fusco R; Catalano O; Piccirillo M; De Bellis M; Izzo F; Petrillo A AJR Am J Roentgenol; 2015 May; 204(5):1000-7. PubMed ID: 25905934 [TBL] [Abstract][Full Text] [Related]
4. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results. Frühling P; Nilsson A; Duraj F; Haglund U; Norén A Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674 [TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series. Sutter O; Calvo J; N'Kontchou G; Nault JC; Ourabia R; Nahon P; Ganne-Carrié N; Bourcier V; Zentar N; Bouhafs F; Sellier N; Diallo A; Seror O Radiology; 2017 Sep; 284(3):877-886. PubMed ID: 28453431 [TBL] [Abstract][Full Text] [Related]
6. Irreversible Electroporation as a Bridge to Liver Transplantation. Cannon RM; Bolus DN; White JA Am Surg; 2019 Jan; 85(1):103-110. PubMed ID: 30760354 [TBL] [Abstract][Full Text] [Related]
7. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up. Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651 [TBL] [Abstract][Full Text] [Related]
8. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins. Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842 [TBL] [Abstract][Full Text] [Related]
9. Ablation of perivascular hepatic malignant tumors with irreversible electroporation. Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820 [TBL] [Abstract][Full Text] [Related]
10. Irreversible Electroporation For Hepatocellular Carcinoma: Longer-Term Outcomes At A Single Centre. Freeman E; Cheung W; Kavnoudias H; Majeed A; Kemp W; Roberts SK Cardiovasc Intervent Radiol; 2021 Feb; 44(2):247-253. PubMed ID: 33051707 [TBL] [Abstract][Full Text] [Related]
12. The Safety and Efficacy of Irreversible Electroporation for Large Hepatocellular Carcinoma. Zeng J; Liu G; Li ZH; Yang Y; Fang G; Li RR; Xu KC; Niu L Technol Cancer Res Treat; 2017 Feb; 16(1):120-124. PubMed ID: 27837054 [TBL] [Abstract][Full Text] [Related]
13. Irreversible Electroporation in Patients with Hepatocellular Carcinoma: Immediate versus Delayed Findings at MR Imaging. Padia SA; Johnson GE; Yeung RS; Park JO; Hippe DS; Kogut MJ Radiology; 2016 Jan; 278(1):285-94. PubMed ID: 26523493 [TBL] [Abstract][Full Text] [Related]
14. Irreversible electroporation for unresectable hepatocellular carcinoma: initial experience and review of safety and outcomes. Cheung W; Kavnoudias H; Roberts S; Szkandera B; Kemp W; Thomson KR Technol Cancer Res Treat; 2013 Jun; 12(3):233-41. PubMed ID: 23369152 [TBL] [Abstract][Full Text] [Related]
15. Irreversible Electroporation in the Treatment of Hepatocellular Carcinoma. Lencioni R; Crocetti L; Narayanan G Tech Vasc Interv Radiol; 2015 Sep; 18(3):135-9. PubMed ID: 26365542 [TBL] [Abstract][Full Text] [Related]
16. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome. Alnaggar M; Lin M; Mesmar A; Liang S; Qaid A; Xu K; Chen J; Niu L; Yin Z Cell Physiol Biochem; 2018; 48(5):1882-1893. PubMed ID: 30092590 [TBL] [Abstract][Full Text] [Related]
17. Irreversible electroporation for nonthermal tumor ablation in patients with hepatocellular carcinoma: initial clinical experience in Japan. Sugimoto K; Moriyasu F; Kobayashi Y; Saito K; Takeuchi H; Ogawa S; Ando M; Sano T; Mori T; Furuichi Y; Nakamura I Jpn J Radiol; 2015 Jul; 33(7):424-32. PubMed ID: 26032929 [TBL] [Abstract][Full Text] [Related]
18. Cancer cells ablation with irreversible electroporation. Miller L; Leor J; Rubinsky B Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891 [TBL] [Abstract][Full Text] [Related]
19. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up. Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569 [TBL] [Abstract][Full Text] [Related]